Engineered probiotic bacteria for tumor delivery of an anti-cancer lasso peptide
Author ORCID
Abstract
Escherichia coli Nissle 1917 (EcN) is used as a natural platform to produce and release an anti-cancer compound to target tumors.
Status
Graduate
Department
Chemistry & Biochemistry
College
College of Arts and Sciences
Campus
Athens
Faculty Mentor
Yong Han
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Engineered probiotic bacteria for tumor delivery of an anti-cancer lasso peptide
Escherichia coli Nissle 1917 (EcN) is used as a natural platform to produce and release an anti-cancer compound to target tumors.